Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RECURSION PHARMACEUTICALS, INC. | Director, 10%+ Owner | Class A Common Stock | 3.73M | $39.4M | $10.58 | Jul 3, 2023 | Indirect |
RECURSION PHARMACEUTICALS, INC. | Director, 10%+ Owner | Class A Common Stock | 9.38K | $99.2K | $10.58 | Jul 3, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RXRX | RECURSION PHARMACEUTICALS, INC. | Jul 3, 2023 | 1 | $0 | 4 | Jul 6, 2023 | Director, 10%+ Owner |
RXRX | RECURSION PHARMACEUTICALS, INC. | Apr 3, 2023 | 1 | $0 | 4 | Apr 5, 2023 | Director, 10%+ Owner |
RXRX | RECURSION PHARMACEUTICALS, INC. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director, 10%+ Owner |
RXRX | RECURSION PHARMACEUTICALS, INC. | Oct 3, 2022 | 1 | $0 | 4 | Oct 5, 2022 | Director, 10%+ Owner |
RXRX | RECURSION PHARMACEUTICALS, INC. | Jul 1, 2022 | 1 | $0 | 4 | Jul 6, 2022 | Director, 10%+ Owner |
RXRX | RECURSION PHARMACEUTICALS, INC. | Apr 1, 2022 | 1 | $0 | 4 | Apr 5, 2022 | Director, 10%+ Owner |
RXRX | RECURSION PHARMACEUTICALS, INC. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director, 10%+ Owner |
RXRX | RECURSION PHARMACEUTICALS, INC. | Oct 1, 2021 | 1 | $0 | 4 | Oct 5, 2021 | Director, 10%+ Owner |
RXRX | RECURSION PHARMACEUTICALS, INC. | Jul 1, 2021 | 1 | $0 | 4 | Jul 6, 2021 | Director, 10%+ Owner |